Canada markets closed

CollPlant Biotechnologies Ltd. (CLGN)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
5.98-0.12 (-1.98%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 68.49M
Enterprise Value 44.97M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)6.21
Price/Book (mrq)2.42
Enterprise Value/Revenue 4.10
Enterprise Value/EBITDA -5.97

Trading Information

Stock Price History

Beta (5Y Monthly) 0.38
52-Week Change 3-15.91%
S&P500 52-Week Change 327.84%
52 Week High 38.90
52 Week Low 34.22
50-Day Moving Average 35.59
200-Day Moving Average 35.71

Share Statistics

Avg Vol (3 month) 36.29k
Avg Vol (10 day) 35.25k
Shares Outstanding 511.45M
Implied Shares Outstanding 611.69M
Float 87.82M
% Held by Insiders 110.16%
% Held by Institutions 112.23%
Shares Short (Apr 30, 2024) 45.76k
Short Ratio (Apr 30, 2024) 41.04
Short % of Float (Apr 30, 2024) 40.07%
Short % of Shares Outstanding (Apr 30, 2024) 40.05%
Shares Short (prior month Mar 28, 2024) 410.83k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 21, 2016
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -64.05%
Operating Margin (ttm)-1,694.98%

Management Effectiveness

Return on Assets (ttm)-13.06%
Return on Equity (ttm)-23.16%

Income Statement

Revenue (ttm)10.96M
Revenue Per Share (ttm)0.96
Quarterly Revenue Growth (yoy)415.50%
Gross Profit (ttm)N/A
EBITDA -6.41M
Net Income Avi to Common (ttm)-7.02M
Diluted EPS (ttm)-0.61
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)26.67M
Total Cash Per Share (mrq)2.33
Total Debt (mrq)3.16M
Total Debt/Equity (mrq)11.15%
Current Ratio (mrq)8.62
Book Value Per Share (mrq)2.47

Cash Flow Statement

Operating Cash Flow (ttm)-2.76M
Levered Free Cash Flow (ttm)-1.9M